|
|
Volumn 40, Issue 6, 2013, Pages 476-477
|
|
Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
C REACTIVE PROTEIN;
CYCLOSPORIN;
ETHAMBUTOL;
ETRETINATE;
INFLIXIMAB;
ISONIAZID;
PREDNISOLONE;
RIFAMPICIN;
STREPTOMYCIN;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CASE REPORT;
COMMON COLD;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE EXACERBATION;
DISEASE SEVERITY;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
EDEMA;
ERYTHRODERMA;
FATIGUE;
FEVER;
GENERAL CONDITION DETERIORATION;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
HYPOTENSION;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LETTER;
LEUKOCYTE COUNT;
LUNG GRANULOMA;
LYMPHADENITIS;
MALE;
MILIARY TUBERCULOSIS;
MYCOBACTERIUM TUBERCULOSIS;
PROTEIN BLOOD LEVEL;
PUSTULAR PSORIASIS;
SPUTUM CULTURE;
THORAX RADIOGRAPHY;
TREATMENT DURATION;
TUBERCULIN TEST;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
HUMANS;
MALE;
MIDDLE AGED;
PSORIASIS;
TUBERCULOSIS, MILIARY;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 84878585020
PISSN: 03852407
EISSN: 13468138
Source Type: Journal
DOI: 10.1111/1346-8138.12118 Document Type: Letter |
|
Times cited : (7)
|
|
References (3)
|
